Otitis Media
2 competing products in clinical development for Otitis Media.
Pipeline by Phase
Phase 1/21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ofloxacin otic solution 0.3% | Daiichi Sankyo | Phase 3 | Completed | 40 |
| piperacillin 4% + tazobactam 0.5% + dexamethasone 0.1% + piperacillin 8% + tazobactam 1.0% + dexamethasone 0.1% + piperacillin 2% + tazobactam 0.25% + piperacillin 4% + tazobactam 0.5% + piperacillin 8% + tazobactam 1.0% | Yuhan | Phase 1/2 | Terminated | 24 |